ALKERMES



Ebitda Alterar Data
AbbVie USD 6.92B 258M 2024-12
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Amgen USD 3.71B 265M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
J&J USD 7.88B 1.76B 2025-03
Malin Corporation EUR -1300000 900K 2024-06
Merck USD 7.12B 1.06B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Otsuka Holdings JPY 144.02B 51.57B 2025-03
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



ALKERMES - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.